{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,7]],"date-time":"2026-02-07T18:17:18Z","timestamp":1770488238882,"version":"3.49.0"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2016,5,13]],"date-time":"2016-05-13T00:00:00Z","timestamp":1463097600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Pharmacokinet Pharmacodyn"],"published-print":{"date-parts":[[2016,6]]},"DOI":"10.1007\/s10928-016-9475-z","type":"journal-article","created":{"date-parts":[[2016,5,13]],"date-time":"2016-05-13T12:51:29Z","timestamp":1463143889000},"page":"325-341","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":22,"title":["Predicting the probability of successful efficacy of a dissociated agonist of the glucocorticoid receptor from dose\u2013response analysis"],"prefix":"10.1007","volume":"43","author":[{"given":"Daniela J.","family":"Conrado","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sriram","family":"Krishnaswami","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Satoshi","family":"Shoji","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sheela","family":"Kolluri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Judith","family":"Hey-Hadavi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dorothy","family":"McCabe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ricardo","family":"Rojo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brinda K.","family":"Tammara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2016,5,13]]},"reference":[{"issue":"3","key":"9475_CR1","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/S0092-8674(00)81109-5","volume":"85","author":"M Feldmann","year":"1996","unstructured":"Feldmann M, Brennan FM, Maini RN (1996) Rheumatoid arthritis. Cell 85(3):307\u2013310","journal-title":"Cell"},{"issue":"9746","key":"9475_CR2","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1016\/S0140-6736(10)60826-4","volume":"376","author":"DL Scott","year":"2010","unstructured":"Scott DL, Wolfe F, Huizinga TW (2010) Rheumatoid arthritis. Lancet 376(9746):1094\u20131108. doi: 10.1016\/S0140-6736(10)60826-4","journal-title":"Lancet"},{"key":"9475_CR3","unstructured":"Centers for disease control and prevention. Rheumatoid arthritis. http:\/\/www.cdc.gov\/arthritis\/basics\/rheumatoid.htm . Accessed Feb 2015"},{"key":"9475_CR4","author":"JS Smolen","year":"2015","unstructured":"Smolen JS, Aletaha D (2015) Rheumatoid arthritis therapy reappraisal: strategies, opportunities and challenges. Nat Rev Rheumatol. doi: 10.1038\/nrrheum.2015.8","journal-title":"Nat Rev Rheumatol"},{"issue":"11","key":"9475_CR5","doi-asserted-by":"crossref","first-page":"1881","DOI":"10.1136\/annrheumdis-2011-200388","volume":"70","author":"F Buttgereit","year":"2011","unstructured":"Buttgereit F (2011) Do the treatment with glucocorticoids and\/or the disease itself drive the impairment in glucose metabolism in patients with rheumatoid arthritis? Ann Rheum Dis 70(11):1881\u20131883. doi: 10.1136\/annrheumdis-2011-200388","journal-title":"Ann Rheum Dis"},{"issue":"4","key":"9475_CR6","first-page":"696","volume":"34","author":"L Caplan","year":"2007","unstructured":"Caplan L, Wolfe F, Russell AS, Michaud K (2007) Corticosteroid use in rheumatoid arthritis: prevalence, predictors, correlates, and outcomes. J Rheumatol 34(4):696\u2013705","journal-title":"J Rheumatol"},{"key":"9475_CR7","doi-asserted-by":"crossref","unstructured":"Criswell L, Saag K, Sems KM, Welch V, Shea B, Wells GA, Suarez-Almazor ME (2009) Moderate-term, low-dose corticosteroids for rheumatoid arthritis. Cochrane Database of Systematic Reviews (1998)","DOI":"10.1002\/14651858.CD001158"},{"key":"9475_CR8","doi-asserted-by":"crossref","unstructured":"Kirwan JR, Bijlsma JWJ, Boers M, Shea B (2009) Effects of glucocorticoids on radiological progression in rheumatoid arthritis (Review). Cochrane Database of Systematic Reviews (2007)","DOI":"10.1002\/14651858.CD006356"},{"issue":"8","key":"9475_CR9","doi-asserted-by":"crossref","first-page":"3123","DOI":"10.1210\/en.2010-1447","volume":"152","author":"X Hu","year":"2011","unstructured":"Hu X, Du S, Tunca C, Braden T, Long KR, Lee J, Webb EG, Dietz JD, Hummert S, Rouw S, Hegde SG, Webber RK, Obukowicz MG (2011) The antagonists but not partial agonists of glucocorticoid receptor ligands show substantial side effect dissociation. Endocrinology 152(8):3123\u20133134. doi: 10.1210\/en.2010-1447","journal-title":"Endocrinology"},{"key":"9475_CR10","unstructured":"DAS28. Radboud University Nijmegen Medical Center. http:\/\/www.das-score.nl\/das28\/en\/introduction-menu.html . Accessed Feb 2015"},{"key":"9475_CR11","unstructured":"US FDA 2013 Guidance for Industry. Rheumatoid Arthritis: Developing Drug Products for Treatment. http:\/\/www.fda.gov\/downloads\/Drugs\/GuidanceComplianceRegulatoryInformation\/Guidances\/UCM354468.pdf"},{"key":"9475_CR12","unstructured":"American College of Rheumatology. 1987 Rheumatoid Arthritis Classification. http:\/\/www.rheumatology.org\/Content.aspx?id=17435 . Accessed April 2015"},{"key":"9475_CR13","unstructured":"R Core Team (2013). R: A language and environment for statistical computing. R Foundation for Statistical Computing, Vienna, Austria. http:\/\/www.R-project.org\/"},{"key":"9475_CR14","unstructured":"Beal S, Sheiner LB, Boeckmann A, Bauer RJ. Nonlinear Mixed Effects Model Program (NONMEM) version 7.2.0, Icon Development Solutions, Ellicott City, MD, USA, 2011. http:\/\/www.iconplc.com\/technology\/products\/nonmem"},{"issue":"2","key":"9475_CR15","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.cmpb.2003.11.003","volume":"75","author":"L Lindbom","year":"2004","unstructured":"Lindbom L, Ribbing J, Jonsson EN (2004) Perl-speaks-NONMEM (PsN)\u2013a Perl module for NONMEM related programming. Comput Methods Programs Biomed 75(2):85\u201394. doi: 10.1016\/j.cmpb.2003.11.003","journal-title":"Comput Methods Programs Biomed"},{"issue":"Suppl 11","key":"9475_CR16","doi-asserted-by":"crossref","first-page":"S14","DOI":"10.1002\/acr.20621","volume":"63","author":"JK Anderson","year":"2011","unstructured":"Anderson JK, Zimmerman L, Caplan L, Michaud K (2011) Measures of rheumatoid arthritis disease activity: Patient (PtGA) and Provider (PrGA) Global Assessment of Disease Activity, Disease Activity Score (DAS) and Disease Activity Score with 28-Joint Counts (DAS28), Simplified Disease Activity Index (SDAI), Clinical Disease Activity Index (CDAI), Patient Activity Score (PAS) and Patient Activity Score-II (PASII), Routine Assessment of Patient Index Data (RAPID), Rheumatoid Arthritis Disease Activity Index (RADAI) and Rheumatoid Arthritis Disease Activity Index-5 (RADAI-5), Chronic Arthritis Systemic Index (CASI), Patient-Based Disease Activity Score With ESR (PDAS1) and Patient-Based Disease Activity Score without ESR (PDAS2), and Mean Overall Index for Rheumatoid Arthritis (MOI-RA). Arthritis Care Res 63(Suppl 11):S14\u2013S36. doi: 10.1002\/acr.20621","journal-title":"Arthritis Care Res"},{"key":"9475_CR17","author":"MM Ward","year":"2014","unstructured":"Ward MM, Guthrie LC, Alba MI (2014) Clinically important changes in individual and composite measures of rheumatoid arthritis activity: thresholds applicable in clinical trials. Ann Rheum Dis. doi: 10.1136\/annrheumdis-2013-205079","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"9475_CR18","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1037\/1082-989X.11.1.54","volume":"11","author":"M Smithson","year":"2006","unstructured":"Smithson M, Verkuilen J (2006) A better lemon squeezer? Maximum-likelihood regression with beta-distributed dependent variables. Psychol Methods 11(1):54\u201371. doi: 10.1037\/1082-989X.11.1.54","journal-title":"Psychol Methods"},{"issue":"6","key":"9475_CR19","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1007\/s10928-014-9375-z","volume":"41","author":"DJ Conrado","year":"2014","unstructured":"Conrado DJ, Denney WS, Chen D, Ito K (2014) An updated Alzheimer\u2019s disease progression model: incorporating non-linearity, beta regression, and a third-level random effect in NONMEM. J Pharmacokinet Pharmacodyn 41(6):581\u2013598. doi: 10.1007\/s10928-014-9375-z","journal-title":"J Pharmacokinet Pharmacodyn"},{"key":"9475_CR20","volume-title":"I Akaike Information Criterion. Encyclopedia of Measurement and Statistics","author":"SAGE Publications","year":"2007","unstructured":"SAGE Publications (2007) I Akaike Information Criterion. Encyclopedia of Measurement and Statistics. SAGE Publications, Inc, Thousand Oaks. doi: 10.4135\/9781412952644"},{"issue":"3","key":"9475_CR21","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1208\/s12248-009-9133-0","volume":"11","author":"RM Savic","year":"2009","unstructured":"Savic RM, Karlsson MO (2009) Importance of shrinkage in empirical bayes estimates for diagnostics: problems and solutions. AAPS J 11(3):558\u2013569. doi: 10.1208\/s12248-009-9133-0","journal-title":"AAPS J"},{"issue":"6","key":"9475_CR22","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1038\/clpt.2013.54","volume":"93","author":"PA Milligan","year":"2013","unstructured":"Milligan PA, Brown MJ, Marchant B, Martin SW, van der Graaf PH, Benson N, Nucci G, Nichols DJ, Boyd RA, Mandema JW, Krishnaswami S, Zwillich S, Gruben D, Anziano RJ, Stock TC, Lalonde RL (2013) Model-based drug development: a rational approach to efficiently accelerate drug development. Clin Pharmacol Ther 93(6):502\u2013514. doi: 10.1038\/clpt.2013.54","journal-title":"Clin Pharmacol Ther"},{"key":"9475_CR23","unstructured":"Dickson MC, Ellis J, Cai G, Wilson AG, Bridges SL, Furst DE, O\u2019Dell JR, El-Gabalawy HS, Tiffany C, Sidiqqi S, Bal J, Uings IJ, Blinks MH, Rioja I (2008) Corticosteroid-responsive pharmacodynamic transcriptional markers: results from a randomised placebo-controlled study of rheumatoid arthritis patients treated with prednisolone. https:\/\/acr.confex.com\/acr\/2008\/webprogram\/Paper2882.html . Paper presented at the American College of Rheumatology. Accessed Mar 2015"},{"issue":"3","key":"9475_CR24","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1136\/ard.2006.054205","volume":"66","author":"E Inoue","year":"2007","unstructured":"Inoue E, Yamanaka H, Hara M, Tomatsu T, Kamatani N (2007) Comparison of Disease Activity Score (DAS)28- erythrocyte sedimentation rate and DAS28- C-reactive protein threshold values. Ann Rheum Dis 66(3):407\u2013409. doi: 10.1136\/ard.2006.054205","journal-title":"Ann Rheum Dis"},{"key":"9475_CR25","unstructured":"University of Missouri\u2013Kansas City. Corticosteroid Conversion Table. http:\/\/med.umkc.edu\/docs\/em\/Corticosteroid_Table.pdf . Accessed Mar 2015"}],"container-title":["Journal of Pharmacokinetics and Pharmacodynamics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10928-016-9475-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10928-016-9475-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10928-016-9475-z","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,7]],"date-time":"2019-09-07T12:49:04Z","timestamp":1567860544000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10928-016-9475-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,5,13]]},"references-count":25,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2016,6]]}},"alternative-id":["9475"],"URL":"https:\/\/doi.org\/10.1007\/s10928-016-9475-z","relation":{},"ISSN":["1567-567X","1573-8744"],"issn-type":[{"value":"1567-567X","type":"print"},{"value":"1573-8744","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,5,13]]}}}